Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis

Journal of Neuroimmunology
Harald Neumann, Kazuya Takahashi

Abstract

While there is a strong evidence for neural tissue destruction mediated by adaptive autoimmune responses, it is still debated how innate immune responses contribute to neuroinflammatory and neurodegenerative diseases such as multiple sclerosis and Alzheimer's disease. Recently, it was shown that loss-of-function mutations of the innate microglial immune receptor triggering receptor expressed on myeloid cells-2 (TREM2) led to a chronic neurodegenerative disease, named Nasu-Hakola disease or polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL). PLOSL is a recessively inherited disease characterized by early onset adult dementia associated with bone cysts. Since microglial cells are the major TREM2-producing cell type in the central nervous system (CNS), they appear to be plausible candidates for the neurodegenerative pathogenesis of PLOSL. Indeed, TREM2 of microglia fulfils important function of tissue debris clearance and resolution of latent inflammatory reactions. Absence of TREM2 expression on microglia impairs their capacity to phagocytose cell membrane debris and increases their gene transcription of pro-inflammatory cytokines. The disease PLOSL and the finding that TREM2 of microglia is requ...Continue Reading

Citations

Apr 3, 2012·Journal of Autism and Developmental Disorders·Nicole A TetreaultJohn M Allman
Apr 25, 2012·Purinergic Signalling·Gary A WeismanLaurie Erb
Jul 25, 2009·Molecular Neurobiology·Marina A Lynch
Nov 16, 2012·The New England Journal of Medicine·Rita GuerreiroAlzheimer Genetic Analysis Group
Oct 17, 2012·Proceedings of the National Academy of Sciences of the United States of America·Nicholas H VarvelMathias Jucker
Jan 1, 2014·Therapeutic Hypothermia and Temperature Management·Masahito KawaboriMidori A Yenari
Jun 24, 2008·Brain : a Journal of Neurology·Harald NeumannR J M Franklin
Feb 2, 2012·Journal of Neuroinflammation·J VinetKnut Biber
May 23, 2013·Alzheimer's Research & Therapy·Todd E GoldeParamita Chakrabarty
Oct 27, 2011·PloS One·Matthias W SieberChristiane Frahm
Aug 17, 2011·International Journal of Environmental Research and Public Health·Andrew D Kraft, G Jean Harry
Jun 4, 2014·Journal of Neuroinflammation·Jonathan D CherryM Kerry O'Banion
Jul 23, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Teng JiangJin-Tai Yu
Mar 19, 2014·Nature Reviews. Neurology·V Hugh Perry, Clive Holmes
Aug 12, 2014·Acta Neuropathologica·Nathalie CartierFabio M V Rossi
Jun 6, 2014·Human Molecular Genetics·Sheng Chih JinCarlos Cruchaga
Mar 7, 2013·Neuroreport·Yuhai ZhaoWalter J Lukiw
Feb 9, 2016·ACS Chemical Neuroscience·Jason D Ulrich, David M Holtzman
Aug 28, 2015·Current Opinion in Genetics & Development·Jorge L Del-AguilaCarlos Cruchaga
Feb 13, 2013·Biological Psychiatry·Sam GandyEric E Schadt
Jan 13, 2016·Molecular Neurodegeneration·Amanda HeslegraveHenrik Zetterberg
Sep 8, 2010·Current Opinion in Neurobiology·Timm SchlegelmilchFrancesca Peri
May 5, 2009·Experimental Neurology·Isabella Napoli, Harald Neumann
Jan 1, 2008·Drug Discovery Today. Disease Models·Monica J CarsonAlison X Xie
Jul 23, 2008·Neuroscience·I Napoli, Harald Neumann
Dec 19, 2014·Rinshō shinkeigaku = Clinical neurology·Kazuya Takahashi
Jun 10, 2008·Journal of Neuroimmunology·Knut BiberHendrikus W G M Boddeke
Oct 24, 2007·Trends in Neurosciences·Knut BiberHendrikus W G M Boddeke
May 22, 2009·Journal of Neurochemistry·Luisa StefanoJacopo Meldolesi
Apr 27, 2011·Journal of Cellular Physiology·Wei Li
Aug 29, 2012·Glia·Melanie Greter, Miriam Merad
Jul 28, 2011·Journal of Cellular Physiology·Nora B CaberoyWei Li
Sep 11, 2013·Neuropathology and Applied Neurobiology·Daisuke NotoSachiko Miyake
Mar 30, 2010·The European Journal of Neuroscience·Daisuke NotoMasahito Yamada
Nov 7, 2009·The American Journal of Pathology·Sadanand GaikwadHarald Neumann
Aug 2, 2015·Archivum Immunologiae Et Therapiae Experimentalis·Zhi-Gang ZhangYou-Qiang Song
Mar 5, 2015·Journal of Cellular Biochemistry·Feiye GuoWei Li
Aug 14, 2012·Journal of Neuroimmunology·Nora B CaberoyWei Li
Jun 12, 2013·Ageing Research Reviews·Wei Li
May 30, 2015·Journal of Neuroinflammation·Rodney M RitzelLouise D McCullough
Jun 20, 2015·Frontiers in Neuroscience·Nicole MaphisKiran Bhaskar
Jul 6, 2014·Cell Stem Cell·Arin B Aurora, Eric N Olson
Apr 24, 2015·Molecular Biology of the Cell·Feiye GuoWei Li
Jun 25, 2013·The Journal of Steroid Biochemistry and Molecular Biology·Pardes HabibJon Dang
Jul 16, 2013·Neurobiology of Learning and Memory·Gary P MorrisBryce Vissel
Sep 28, 2014·Neurobiology of Aging·Deana FinelliStuart Pickering-Brown
Feb 6, 2013·Proceedings of the National Academy of Sciences of the United States of America·Giuseppe MatareseChristos S Mantzoros
Jul 24, 2014·Molecular Neurobiology·Jing MaJin-Tai Yu
Apr 20, 2014·Frontiers in Cellular Neuroscience·Brandon M JonesWalter J Lukiw
Jan 30, 2015·Acta Neuropathologica·Claudia CantoniLaura Piccio
Nov 19, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Tarja M MalmGary E Landreth
May 18, 2016·Cell Biology and Toxicology·Xiuping ChenWei Li
May 21, 2015·PloS One·Ying DingWei Li
Feb 11, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Joris R Delanghe, Marijn M Speeckaert
Mar 14, 2017·Laboratory Investigation; a Journal of Technical Methods and Pathology·Anna GieryngBozena Kaminska
Jan 25, 2018·International Journal of Molecular Sciences·Carmen MeccaCataldo Arcuri
Dec 28, 2017·Journal of Alzheimer's Disease : JAD·Ruma Raha-ChowdhuryShahid H Zaman
Jan 30, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M CasatiB Arosio
Sep 14, 2010·Nature Reviews. Neurology·Marino M BianchinCarlos R de Mello Rieder
Jul 11, 2018·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·David Alvarez-CarbonellJonathan Karn
Nov 12, 2010·Nature·Richard M Ransohoff, Astrid E Cardona
Aug 12, 2015·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·T A VoldenS J Bonasera
Aug 5, 2017·Molecular Neurodegeneration·Taylor R JayGary E Landreth
Dec 31, 2019·PLoS Pathogens·David Alvarez-CarbonellJonathan Karn
Dec 21, 2018·Neurology. Neuroimmunology and Neuroinflammation·Magnus GisslénHenrik Zetterberg
Feb 18, 2020·Brain : a Journal of Neurology·Edward N WilsonKatrin I Andreasson
May 11, 2013·Alzheimer's Research & Therapy·Lorraine Fuhrmann Clark, Thomas Kodadek
Nov 20, 2016·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Atsushi Sasaki
Oct 16, 2018·Frontiers in Cellular Neuroscience·Zsuzsanna SzepesiTomas Deierborg
Jan 11, 2020·Frontiers in Aging Neuroscience·Georgia R FrostYue-Ming Li
Sep 7, 2018·Frontiers in Cellular Neuroscience·Md Ezazul HaqueDong-Kug Choi
Dec 14, 2018·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Kota KurisuMidori A Yenari
Oct 9, 2019·Journal of Alzheimer's Disease : JAD·Francesca La RosaMario Clerici
Apr 15, 2020·Experimental & Molecular Medicine·Sun Ah ParkChae Eun Kim
Jul 9, 2020·Journal of Neuroinflammation·Jiaolong YangZhentao Zhang
Mar 23, 2017·Nature Immunology·Marco PrinzNora Hagemeyer
Sep 21, 2018·Proceedings of the National Academy of Sciences of the United States of America·Faten A SayedLi Gan
Mar 3, 2020·Frontiers in Neurology·Wurong LiXinghu Zhang
Dec 23, 2018·Molecular Neurodegeneration·Maud GratuzeDavid M Holtzman
May 10, 2019·Molecular Neurodegeneration·Jorge L Del-AguilaCarlos Cruchaga
Apr 21, 2020·International Immunopharmacology·Mengmeng YouFuliang Hu
Mar 3, 2021·CNS Neuroscience & Therapeutics·Ke WangYanqin Gao
Mar 3, 2021·Acta Neuropathologica Communications·Selva BaltanBruce D Trapp
Mar 13, 2021·Frontiers in Immunology·Raffaella MoriniMichela Matteoli
Apr 1, 2021·Frontiers in Cellular Neuroscience·Keith E Campagno, Claire H Mitchell
Apr 25, 2018·Journal of Neuroimmunology·L M BekrisJ B Leverenz

Related Concepts

Related Feeds

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.